Last update:
Oncology news
Tumor index can identify breast cancer patients' drug response
Researchers at The Hong Kong Polytechnic University (PolyU) have developed an imaging biomarker, the Tumour Heterogeneity Index (THI), which enables noninvasive assessment of breast cancer patients' response to AKT inhibitors ...
10 hours ago
0
13
Newly discovered pathway fuels production of cancer-driving proteins
A previously unknown mechanism helps cancer cells selectively produce proteins that drive tumor growth—such as KRAS—in common cancers, according to new research from The University of Texas MD Anderson Cancer Center. The ...
19 hours ago
0
107
Reversing radiation-activated immune suppression in cancer
Researchers at the University of Chicago have identified a mechanism to make immune cells reprogrammed by radiation therapy attack tumors rather than protect them. The study, published in Cancer Cell, shows that radiation ...
Oct 31, 2026
0
80
Cholesterol-sharing mechanism points to potential new target for pancreatic cancer treatment
Fox Chase Cancer Center researchers identified a potential therapeutic target for pancreatic cancer after showing that tumor growth can be slowed and immune suppression can be reduced in preclinical trials by blocking a particular ...
Oct 30, 2026
0
447
Space-grown glioblastoma organoids could help advance brain cancer treatments
Glioblastoma (GBM) is the most common malignant primary brain tumor in adults and is one of the most aggressive and deadly forms of cancer. It is difficult for surgeons to fully remove GBM because it often has microscopic ...
Oct 30, 2026
0
55
Checkpoint immunotherapy reshapes immune environment in lymph nodes after melanoma reaches them
A new study from Mayo Clinic suggests checkpoint immunotherapy may reshape the immune environment within lymph nodes after melanoma has spread to them. Researchers found that treatment reorganized several types of immune ...
Oct 30, 2026
0
55
CDK1 protein offers clues to which breast cancers will resist targeted therapy
Researchers at the Garvan Institute of Medical Research have discovered that the activity of a protein called CDK1 in breast cancers is linked to how they respond to a common therapy—an insight that could inform more personalized ...
Oct 30, 2026
0
31
Platelets may play an unexpected role in glioblastoma progression
New Cleveland Clinic research published in Cancer Cell shows that people with glioblastoma have more active platelets, which are cells involved in blood clotting. Platelets also communicate with other cells and can influence ...
Oct 30, 2026
0
12
Cancer-promoting proteins may make tumors easier to spot... but also help them evade immune attack
The immune system may recognize a cancer cell and still fail to destroy it. In a recent study, researchers at Hiroshima University and their international collaborators found that hyperactive YAP and TAZ (YAP/TAZ), two cancer-promoting ...
Oct 30, 2026
0
10
How mental health and cancer survivorship intersect
A Stanford Medicine study identified an often-overlooked period of vulnerability for cancer survivors: Mental health disorders identified two to five years after a cancer diagnosis were associated with a 119% higher rate ...
Oct 30, 2026
0
7
Breast cancer drug raises creatinine without necessarily signaling kidney damage, study finds
A routine blood test can make a kidney look like it is failing when it is not. A team from Kanazawa University and Shinshu University has shown that this happens often in patients with breast cancer who take abemaciclib, ...
Oct 30, 2026
0
31
New swab test could spare some women a painful biopsy for endometrial cancer
A simple vaginal swab may one day help women with abnormal bleeding learn whether they have endometrial cancer without first going through a painful biopsy.
Oct 30, 2026
0
9
Alcohol use held steady among cancer survivors
The drinking rate of adults who have had cancer has remained unchanged for nearly a decade, according to a new study by researchers at the WashU Brown School.
Oct 30, 2026
0
6
Colorectal cancer in younger patients shows distinct cellular and gene-activity patterns
Mass General Brigham researchers from the Gene Lay Institute of Immunology and Inflammation, along with researchers at Dana-Farber Cancer Institute and the Broad Institute, have uncovered biological clues to why colorectal ...
Oct 29, 2026
0
296
Immune system protein is a cancer killer on its own, new study shows
For decades, scientists have known that a protein made by T cells and natural killer (NK) cells in the immune system, called perforin, can kill tumor cells by punching a hole in the cell wall and injecting proteases called ...
Oct 29, 2026
0
26
Immune changes linked to diabetes could guide development of new cancer treatments
New research in The Journal of Immunology uncovers how high blood sugar (hyperglycemia) and type 1 diabetes (T1D) may protect against certain cancers like melanoma, breast and colon cancer. T1D has been associated with a ...
Oct 29, 2026
0
48
Known for preventing cancer, p53 could also help immune cells fight it
Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a new strategy to make cancer-fighting immune cells stronger and potentially longer-lasting, a discovery that could help improve the effectiveness ...
Oct 29, 2026
0
331
Tumor mutations and immune activity may reveal who benefits from investigational lymphoma drug
Researchers at the University of Tsukuba conducted a physician-initiated phase 2 clinical trial of dasatinib in patients with relapsed or refractory T-follicular helper cell lymphoma (TFHL), an aggressive and difficult-to-treat ...
Oct 29, 2026
0
8
Antibody candidate could help preserve appetite and muscle strength in patients with cancer
In cancer cachexia, patients continue to lose weight, muscle and fat even when they eat. A KAIST research team has developed a therapeutic candidate that blocks a signal responsible for appetite suppression, weight loss and ...
Oct 29, 2026
0
8
Blood test offers new way to track lung cancer
Northwestern Medicine scientists and collaborators have demonstrated a novel liquid biopsy technique that can measure cancer burden and reveal molecular characteristics of small cell lung cancer (SCLC), according to a new ...
Oct 29, 2026
0
7
Researchers identify critical window for boosting immunotherapy response in prostate cancer
Researchers at Roswell Park Comprehensive Cancer Center have shown that hormone-blocking therapies commonly used to treat prostate cancers temporarily activate the body's immune response before those immune effects begin ...
Oct 29, 2026
0
10
Healthy diet may lower heart disease risk after cancer
Eating a healthy diet is associated with a reduced risk of heart disease and death among cancer survivors, according to a study published today in JACC: Advances.
Oct 29, 2026
0
9
Residential fine particulate matter linked to minimal residual disease in pediatric leukemia
For pediatric patients with high-risk B-cell acute lymphoblastic leukemia (B-ALL), residential fine particulate matter (PM₂.₅) concentrations during induction therapy are associated with positive end-of-induction (EOI) minimal ...
Oct 29, 2026
0
4
Personalized ovarian cancer vaccines spark immunity in phase 1 trial
Rapidly dividing cancer cells can develop DNA mutations that produce abnormal proteins called antigens, which are unique to each patient's cancer. Scientists are now testing personalized cancer vaccines that target these ...
Arsenic drug combo resurrects 'guardian of the genome' to fight aggressive blood cancers
A combination cancer therapy that relies on the reactivation of a tumor suppressor protein to kill leukemic and other blood cancer cells has shown promise in a small pilot trial.
